5th Annual FDA/AD Allies Meeting: Pursuing Combination Therapy Development for Alzheimer's Disease

Date(s): 
11/29/2012
Location: 
Hilton Hotel Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852
Fees: 
Please contact the event's organizers for more details
Sponsor(s): 

The primary goal of this meeting will be to explore collaborative partnerships in the development of combination therapies for Alzheimer's disease (AD). The Food and Drug Administration (FDA)'s draft guidance on the development of multiple therapies in combination for AD treatment will also be discussed.

More information about the meeting may be found at www.agingresearch.org/content/calendar/detail/19964

Continuing Education Credits: 
Please contact the event's organizers for more details
Contact Person(s): 

Dina Beaumont

Email:  dinabeau [ at ] aol [dot] com

AttachmentSize
file_ACT_AD_Fall_2012_Agenda[1].pdf149.5 KB